Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.


Player Avatar bobbyvee (96.77) Submitted: 3/7/2009 11:48:54 AM : Underperform Start Price: $21.25 LLY Score: -31.47

Pharaceuticals will suffer under this administration's plan for universal care

Report this Post 4 Replies
Member Avatar wrparks (69.40) Submitted: 6/2/2009 9:15:16 AM
Recs: 4

I disagree. I think their margins may be squeezed due to lower drug prices. But, I expect their volume may increase offsetting this. I'm not highly confident they will outperform, but I don't think your explanation is a very good one.

Member Avatar withoutlimits (83.21) Submitted: 6/6/2010 1:53:20 AM
Recs: 0

In any case, these scumbags sell more harmful drugs to Americans than all the drug lords in Columbia.

Member Avatar blake303 (29.31) Submitted: 9/20/2010 2:01:10 PM
Recs: 0

A sale (legal or not) takes a willing buyer

Member Avatar Gekko25 (< 20) Submitted: 6/28/2011 7:17:55 PM
Recs: 0

Obama out in 2012, if were not all dead

Featured Broker Partners